City View Green Holdings Inc. (CVGR.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.01 Million CAD | 47.94% |
| 2022 | -1.26 Million CAD | 21.35% |
| 2021 | -3.02 Million CAD | 65.15% |
| 2020 | -4.63 Million CAD | 2.05% |
| 2019 | -22.93 Million CAD | -420.95% |
| 2018 | -957.5 Thousand CAD | -200.84% |
| 2017 | - CAD | -164.01% |
| 2016 | -119.56 Thousand CAD | 5.47% |
| 2015 | -149.91 Thousand CAD | 32.5% |
| 2014 | -18.79 Thousand CAD | 51.02% |
| 2013 | -2.18 Million CAD | 61.48% |
| 2012 | -1.23 Million CAD | -168.46% |
| 2011 | 1.46 Million CAD | 181.0% |
| 2010 | -2.08 Million CAD | -2283.36% |
| 2009 | -1.64 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -155.64 Thousand CAD | 94.66% |
| 2024 Q2 | -219.63 Thousand CAD | -79.18% |
| 2023 Q2 | -167.99 Thousand CAD | -3.46% |
| 2023 Q4 | -159.49 Thousand CAD | 19.25% |
| 2023 FY | - CAD | 47.94% |
| 2023 Q1 | -162.38 Thousand CAD | 58.16% |
| 2023 Q3 | -197.5 Thousand CAD | -17.56% |
| 2022 FY | - CAD | 21.35% |
| 2022 Q4 | -388.13 Thousand CAD | -17.97% |
| 2022 Q3 | -329.01 Thousand CAD | 5.93% |
| 2022 Q2 | -349.75 Thousand CAD | -28.51% |
| 2022 Q1 | -272.16 Thousand CAD | 70.28% |
| 2021 Q2 | -266.27 Thousand CAD | 0.12% |
| 2021 Q4 | -915.8 Thousand CAD | -260.59% |
| 2021 Q1 | -266.59 Thousand CAD | 88.25% |
| 2021 FY | - CAD | 65.15% |
| 2021 Q3 | -253.97 Thousand CAD | 4.62% |
| 2020 Q1 | -586.37 Thousand CAD | 62.74% |
| 2020 FY | - CAD | 2.05% |
| 2020 Q2 | -191.62 Thousand CAD | 67.32% |
| 2020 Q3 | -1.83 Million CAD | -859.5% |
| 2020 Q4 | -2.26 Million CAD | -23.42% |
| 2019 Q2 | -1.74 Million CAD | -123.74% |
| 2019 Q3 | -895.83 Thousand CAD | 48.54% |
| 2019 Q4 | -1.57 Million CAD | -75.65% |
| 2019 FY | - CAD | -420.95% |
| 2019 Q1 | -778 Thousand CAD | -544.84% |
| 2018 Q1 | -641.69 Thousand CAD | -411.38% |
| 2018 Q2 | -115.17 Thousand CAD | 82.05% |
| 2018 Q4 | -120.65 Thousand CAD | -50.84% |
| 2018 FY | - CAD | -200.84% |
| 2018 Q3 | -79.98 Thousand CAD | 30.55% |
| 2017 Q3 | -72.23 Thousand CAD | -39.4% |
| 2017 Q2 | -51.81 Thousand CAD | 24.62% |
| 2017 Q1 | -68.74 Thousand CAD | -4.34% |
| 2017 FY | - CAD | -164.01% |
| 2017 Q4 | -125.48 Thousand CAD | -73.71% |
| 2016 FY | - CAD | 5.47% |
| 2016 Q3 | -15.65 Thousand CAD | 10.52% |
| 2016 Q1 | -21.52 Thousand CAD | -15.38% |
| 2016 Q4 | -65.87 Thousand CAD | -320.76% |
| 2016 Q2 | -17.49 Thousand CAD | 18.69% |
| 2015 Q3 | -31.27 Thousand CAD | -48.56% |
| 2015 Q4 | -18.65 Thousand CAD | 40.35% |
| 2015 FY | - CAD | 32.5% |
| 2015 Q2 | -21.04 Thousand CAD | 61.73% |
| 2015 Q1 | -55 Thousand CAD | 9.53% |
| 2014 Q4 | -60.8 Thousand CAD | -59.85% |
| 2014 Q3 | -38.03 Thousand CAD | 20.46% |
| 2014 FY | - CAD | 51.02% |
| 2014 Q1 | -42.26 Thousand CAD | 31.42% |
| 2014 Q2 | -47.82 Thousand CAD | -13.15% |
| 2013 Q3 | -70.71 Thousand CAD | 39.55% |
| 2013 Q4 | -61.63 Thousand CAD | 12.84% |
| 2013 FY | - CAD | 61.48% |
| 2013 Q1 | -154.51 Thousand CAD | 43.37% |
| 2013 Q2 | -116.97 Thousand CAD | 24.3% |
| 2012 Q4 | -272.83 Thousand CAD | -75.31% |
| 2012 Q2 | -301.51 Thousand CAD | -11.07% |
| 2012 Q1 | -271.45 Thousand CAD | -108.66% |
| 2012 Q3 | -155.62 Thousand CAD | 48.39% |
| 2012 FY | - CAD | -168.46% |
| 2011 Q3 | -383.69 Thousand CAD | 61.0% |
| 2011 Q1 | -227 Thousand CAD | 41.44% |
| 2011 Q4 | 3.13 Million CAD | 917.37% |
| 2011 Q2 | -983.93 Thousand CAD | -333.44% |
| 2011 FY | - CAD | 181.0% |
| 2010 Q2 | -490.21 Thousand CAD | -14.62% |
| 2010 Q3 | -503.09 Thousand CAD | -2.63% |
| 2010 FY | - CAD | -2283.36% |
| 2010 Q4 | -387.67 Thousand CAD | 22.94% |
| 2010 Q1 | -427.68 Thousand CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 66.833% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | -0.197% |
| Blueberries Medical Corp. | -1.22 Million CAD | -64.878% |
| The BC Bud Corporation | -1.19 Million CAD | -68.431% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 68.935% |
| CordovaCann Corp. | -1.6 Million CAD | -25.698% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 23.213% |
| Captor Capital Corp. | 2.42 Million CAD | 183.202% |
| 1CM Inc. | 1.31 Million CAD | 253.363% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -8025.12% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 8.782% |
| IM Cannabis Corp. | -2.79 Million CAD | 27.797% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 54.241% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -413.61% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 36.91% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 276.459% |
| Ovation Science Inc. | -778.83 Thousand CAD | -158.652% |
| Pharmadrug Inc. | -1.33 Million CAD | -50.894% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 66.737% |
| RAMM Pharma Corp. | -6.3 Million CAD | 68.035% |
| RIV Capital Inc. | -20.28 Million CAD | 90.067% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 63.995% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 97.404% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 31.73% |
| 1933 Industries Inc. | -10.03 Million CAD | 79.922% |
| Red Light Holland Corp. | -5.25 Million CAD | 61.672% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -162.302% |
| Xebra Brands Ltd. | -1.49 Million CAD | -34.747% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -42.742% |